Page last updated: 2024-11-01

omeprazole and MODS

omeprazole has been researched along with MODS in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yusoff, IF1
Nairn, P1
Morgan, CA1
Dehesa, C1
Kassel, G1

Other Studies

2 other studies available for omeprazole and MODS

ArticleYear
Multiple organ failure related to pantoprazole.
    Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acidosis, Lactic; Acute Kidney Injury; Aged; Anti-Ulcer Age

1999
Multiple organ failure and pantoprazole.
    Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Multiple Organ F

2000